ACET Adicet Bio | $6.35
-29.6% | 9/28/2026 | | Boost Price Target | $27.00 ➝ $34.00 | Buy | 00.00% | View details for HC Wainwright rating of Adicet Bio (NASDAQ:ACET) on 9/28/2026 |
INCY Incyte | $124.82
+0.8% | 9/28/2026 | | Boost Price Target | $150.00 ➝ $152.00 | Buy | 00.00% | View details for HC Wainwright rating of Incyte (NASDAQ:INCY) on 9/28/2026 |
KOD Kodiak Sciences | $89.92
+178.0% | 9/28/2026 | | Boost Price Target | $58.00 ➝ $96.00 | Buy | 00.00% | View details for HC Wainwright rating of Kodiak Sciences (NASDAQ:KOD) on 9/28/2026 |
MIRM Mirum Pharmaceuticals | $87.96
-1.9% | 9/28/2026 | | Boost Price Target | $140.00 ➝ $195.00 | Buy | 00.00% | View details for HC Wainwright rating of Mirum Pharmaceuticals (NASDAQ:MIRM) on 9/28/2026 |
BDSX Biodesix | $30.42
+4.5% | 9/25/2026 | | Reiterated Rating | $27.00 ➝ $38.00 | Buy | 00.00% | View details for HC Wainwright rating of Biodesix (NASDAQ:BDSX) on 9/25/2026 |
CIFR Cipher Mining | $16.74
-5.6% | 9/25/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Cipher Mining (NASDAQ:CIFR) on 9/25/2026 |
MCD McDonald's | $233.32
-1.3% | 9/25/2026 | | Set Price Target | $250.00 | | 00.00% | View details for HC Wainwright rating of McDonald’s (NYSE:MCD) on 9/25/2026 |
COYA Coya Therapeutics | $4.98
-2.0% | 9/25/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Coya Therapeutics (NASDAQ:COYA) on 9/25/2026 |
ABEO Abeona Therapeutics | $5.29
-2.0% | 9/25/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Abeona Therapeutics (NASDAQ:ABEO) on 9/25/2026 |
KYTX Kyverna Therapeutics | $6.82
+0.1% | 9/25/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Kyverna Therapeutics (NASDAQ:KYTX) on 9/25/2026 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. |
SRZN Surrozen | $29.64
+0.3% | 9/25/2026 | | Reiterated Rating | $44.00 ➝ $54.00 | Buy | 00.00% | View details for HC Wainwright rating of Surrozen (NASDAQ:SRZN) on 9/25/2026 |
AXSM Axsome Therapeutics | $193.89
-0.6% | 9/25/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Axsome Therapeutics (NASDAQ:AXSM) on 9/25/2026 |
CGEM Cullinan Therapeutics | $14.95
+0.9% | 9/25/2026 | | Boost Price Target | $30.00 ➝ $35.00 | Buy | 00.00% | View details for HC Wainwright rating of Cullinan Therapeutics (NASDAQ:CGEM) on 9/25/2026 |
ACAD ACADIA Pharmaceuticals | $20.53
-0.7% | 9/25/2026 | | Lower Price Target | $37.00 ➝ $33.00 | Buy | 00.00% | View details for HC Wainwright rating of ACADIA Pharmaceuticals (NASDAQ:ACAD) on 9/25/2026 |
RZLT Rezolute | $4.18
+7.2% | 9/25/2026 | | Boost Price Target | $5.00 ➝ $10.00 | Buy | 00.00% | View details for HC Wainwright rating of Rezolute (NASDAQ:RZLT) on 9/25/2026 |
TLX Telix Pharmaceuticals | $11.62
+1.5% | 9/25/2026 | | Reiterated Rating | $20.00 | Buy | 00.00% | View details for HC Wainwright rating of Telix Pharmaceuticals (NASDAQ:TLX) on 9/25/2026 |
ACIU AC Immune | $2.61
+3.6% | 9/24/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of AC Immune (NASDAQ:ACIU) on 9/24/2026 |
IMVT Immunovant | $33.49
+0.6% | 9/24/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Immunovant (NASDAQ:IMVT) on 9/24/2026 |
PRAX Praxis Precision Medicines | $285.65
+1.7% | 9/24/2026 | | Reiterated Rating | $1,201.00 | Buy | 00.00% | View details for HC Wainwright rating of Praxis Precision Medicines (NASDAQ:PRAX) on 9/24/2026 |
IONS Ionis Pharmaceuticals | $45.57
+2.4% | 9/24/2026 | | Reiterated Rating | $100.00 | Buy | 00.00% | View details for HC Wainwright rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 9/24/2026 |
LGND Ligand Pharmaceuticals | $314.10
+4.2% | 9/24/2026 | | Reiterated Rating | $358.00 | Buy | 00.00% | View details for HC Wainwright rating of Ligand Pharmaceuticals (NASDAQ:LGND) on 9/24/2026 |
MAZE Maze Therapeutics | $26.85
+3.1% | 9/24/2026 | | Reiterated Rating | $110.00 | Buy | 00.00% | View details for HC Wainwright rating of Maze Therapeutics (NASDAQ:MAZE) on 9/24/2026 |
NVCT Nuvectis Pharma | $20.81
+2.9% | 9/24/2026 | | Reiterated Rating | $39.00 | Buy | 00.00% | View details for HC Wainwright rating of Nuvectis Pharma (NASDAQ:NVCT) on 9/24/2026 |
ORKA Oruka Therapeutics | $84.19
-0.3% | 9/24/2026 | | Reiterated Rating | $120.00 | Buy | 00.00% | View details for HC Wainwright rating of Oruka Therapeutics (NASDAQ:ORKA) on 9/24/2026 |
USAS Americas Gold and Silver | $4.50
-6.8% | 9/24/2026 | | Reiterated Rating | $9.25 | Buy | 00.00% | View details for HC Wainwright rating of Americas Gold and Silver (NYSEAMERICAN:USAS) on 9/24/2026 |
ADUR Aduro Clean Technologies | $12.31
-2.5% | 9/23/2026 | | Reiterated Rating | $22.00 | Buy | 00.00% | View details for HC Wainwright rating of Aduro Clean Technologies (NASDAQ:ADUR) on 9/23/2026 |
CRDL Cardiol Therapeutics | $1.69
-1.2% | 9/23/2026 | | Reiterated Rating | $9.00 | Buy | 00.00% | View details for HC Wainwright rating of Cardiol Therapeutics (NASDAQ:CRDL) on 9/23/2026 |
ENTA Enanta Pharmaceuticals | $12.61
+6.1% | 9/23/2026 | | Reiterated Rating | $20.00 | Buy | 00.00% | View details for HC Wainwright rating of Enanta Pharmaceuticals (NASDAQ:ENTA) on 9/23/2026 |
PALI Palisade Bio | $1.50
+3.4% | 9/23/2026 | | Reiterated Rating | $7.00 | Buy | 00.00% | View details for HC Wainwright rating of Palisade Bio (NASDAQ:PALI) on 9/23/2026 |
SMMT Summit Therapeutics | $15.48
-0.8% | 9/23/2026 | | Reiterated Rating | | Neutral | 00.00% | View details for HC Wainwright rating of Summit Therapeutics (NASDAQ:SMMT) on 9/23/2026 |
TLSI TriSalus Life Sciences | $4.39
+1.2% | 9/23/2026 | | Boost Price Target | $11.00 ➝ $12.00 | Buy | 00.00% | View details for HC Wainwright rating of TriSalus Life Sciences (NASDAQ:TLSI) on 9/23/2026 |
VKTX Viking Therapeutics | $33.03
-7.1% | 9/22/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Viking Therapeutics (NASDAQ:VKTX) on 9/22/2026 |
ANAB AnaptysBio | $50.80
-0.4% | 9/22/2026 | | Reiterated Rating | $95.00 | Buy | 00.00% | View details for HC Wainwright rating of AnaptysBio (NASDAQ:ANAB) on 9/22/2026 |
ARMP Armata Pharmaceuticals | $3.78
+1.1% | 9/22/2026 | | Reiterated Rating | $15.00 | Buy | 00.00% | View details for HC Wainwright rating of Armata Pharmaceuticals (NYSEAMERICAN:ARMP) on 9/22/2026 |
ANIX Anixa Biosciences | $2.79
+0.4% | 9/22/2026 | | Lower Price Target | $7.00 ➝ $6.00 | Buy | 00.00% | View details for HC Wainwright rating of Anixa Biosciences (NASDAQ:ANIX) on 9/22/2026 |
BEAT HeartBeam | $0.37
+3.7% | 9/22/2026 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for HC Wainwright rating of HeartBeam (NASDAQ:BEAT) on 9/22/2026 |
CLDX Celldex Therapeutics | $31.49
+1.3% | 9/22/2026 | | Boost Price Target | $42.00 ➝ $64.00 | Buy | 00.00% | View details for HC Wainwright rating of Celldex Therapeutics (NASDAQ:CLDX) on 9/22/2026 |
ELE Elemental Royalty | $19.69
-5.1% | 9/22/2026 | | Lower Price Target | $33.00 ➝ $31.00 | Buy | 00.00% | View details for HC Wainwright rating of Elemental Royalty (NASDAQ:ELE) on 9/22/2026 |
PHAR Pharming Group | $10.52
+0.6% | 9/22/2026 | | Reiterated Rating | $37.00 | Buy | 00.00% | View details for HC Wainwright rating of Pharming Group (NASDAQ:PHAR) on 9/22/2026 |
TVTX Travere Therapeutics | $61.57
+3.6% | 9/22/2026 | | Reiterated Rating | $67.00 | Buy | 00.00% | View details for HC Wainwright rating of Travere Therapeutics (NASDAQ:TVTX) on 9/22/2026 |
Elon Musk’s Hushed FCC Filing. Dec 8th. (Ad) Elon Musk quietly filed a document with the federal government tied to artificial intelligence, one of the largest markets in the world.
James Altucher, who previously flagged Nvidia in 2008 and Bitcoin in 2013, says the filing could rival Tesla, SpaceX and xAI combined.
Few investors know this filing exists, but that is expected to change quickly. Click here to see details on Elon Musk's newest AI filing |
TYRA Tyra Biosciences | $21.45
-1.4% | 9/22/2026 | | Lower Price Target | $30.00 ➝ $29.00 | Buy | 00.00% | View details for HC Wainwright rating of Tyra Biosciences (NASDAQ:TYRA) on 9/22/2026 |
VGZ Vista Gold | $2.69
-2.2% | 9/22/2026 | | Reiterated Rating | $4.50 | Buy | 00.00% | View details for HC Wainwright rating of Vista Gold (NYSEAMERICAN:VGZ) on 9/22/2026 |
ALKS Alkermes | $40.15
-1.7% | 9/21/2026 | | Reiterated Rating | | Neutral | 00.00% | View details for HC Wainwright rating of Alkermes (NASDAQ:ALKS) on 9/21/2026 |
IPHA Innate Pharma | $1.70
| 9/21/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Innate Pharma (NASDAQ:IPHA) on 9/21/2026 |
ALNY Alnylam Pharmaceuticals | $255.36
-0.2% | 9/21/2026 | | Reiterated Rating | $455.00 | Buy | 00.00% | View details for HC Wainwright rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 9/21/2026 |
EWTX Edgewise Therapeutics | $39.79
+1.1% | 9/21/2026 | | Boost Price Target | $45.00 ➝ $57.00 | Buy | 00.00% | View details for HC Wainwright rating of Edgewise Therapeutics (NASDAQ:EWTX) on 9/21/2026 |
JOBY Joby Aviation | $6.11
-3.4% | 9/21/2026 | | Reiterated Rating | $18.00 | Buy | 00.00% | View details for HC Wainwright rating of Joby Aviation (NYSE:JOBY) on 9/21/2026 |
LPCN Lipocine | $2.09
-0.5% | 9/21/2026 | | Reiterated Rating | $4.00 | Neutral | 00.00% | View details for HC Wainwright rating of Lipocine (NASDAQ:LPCN) on 9/21/2026 |
XENE Xenon Pharmaceuticals | $36.72
-0.6% | 9/18/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Xenon Pharmaceuticals (NASDAQ:XENE) on 9/18/2026 |
ACET Adicet Bio | $6.35
-29.6% | 9/18/2026 | | Reiterated Rating | $27.00 | Buy | 00.00% | View details for HC Wainwright rating of Adicet Bio (NASDAQ:ACET) on 9/18/2026 |
CORT Corcept Therapeutics | $115.63
-0.4% | 9/18/2026 | | Reiterated Rating | $165.00 | Buy | 00.00% | View details for HC Wainwright rating of Corcept Therapeutics (NASDAQ:CORT) on 9/18/2026 |
OCS Oculis | $9.06
-2.3% | 9/18/2026 | | Boost Price Target | $26.00 ➝ $39.00 | Buy | 00.00% | View details for HC Wainwright rating of Oculis (NASDAQ:OCS) on 9/18/2026 |
IBIO iBio | $1.17
-1.7% | 9/17/2026 | | Initiated Coverage | $7.00 | Buy | 00.00% | View details for HC Wainwright rating of iBio (NASDAQ:IBIO) on 9/17/2026 |
IBIO iBio | $1.17
-1.7% | 9/17/2026 | | Initiated Coverage | $7.00 | Buy | 00.00% | View details for HC Wainwright rating of iBio (NASDAQ:IBIO) on 9/17/2026 |
KOD Kodiak Sciences | $89.92
+178.0% | 9/17/2026 | | Reiterated Rating | $58.00 | Buy | 00.00% | View details for HC Wainwright rating of Kodiak Sciences (NASDAQ:KOD) on 9/17/2026 |
LFMD LifeMD | $2.93
-1.3% | 9/17/2026 | | Reiterated Rating | $9.00 | Buy | 00.00% | View details for HC Wainwright rating of LifeMD (NASDAQ:LFMD) on 9/17/2026 |
AGMB AgomAb Therapeutics | $10.21
-2.9% | 9/16/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of AgomAb Therapeutics (NASDAQ:AGMB) on 9/16/2026 |
OCUL Ocular Therapeutix | $7.66
-20.6% | 9/16/2026 | | Reiterated Rating | $25.00 | Buy | 00.00% | View details for HC Wainwright rating of Ocular Therapeutix (NASDAQ:OCUL) on 9/16/2026 |
SRRK Scholar Rock | $49.13
+1.0% | 9/15/2026 | | Boost Price Target | $65.00 ➝ $70.00 | Buy | 00.00% | View details for HC Wainwright rating of Scholar Rock (NASDAQ:SRRK) on 9/15/2026 |
CRDF Cardiff Oncology | $1.20
-3.2% | 9/15/2026 | | Upgrade | | Neutral ➝ Buy | 00.00% | View details for HC Wainwright rating of Cardiff Oncology (NASDAQ:CRDF) on 9/15/2026 |
COGT Cogent Biosciences | $31.86
-1.4% | 9/15/2026 | | Reiterated Rating | $55.00 | Buy | 00.00% | View details for HC Wainwright rating of Cogent Biosciences (NASDAQ:COGT) on 9/15/2026 |
TLX Telix Pharmaceuticals | $11.62
+1.5% | 9/15/2026 | | Reiterated Rating | $20.00 | Buy | 00.00% | View details for HC Wainwright rating of Telix Pharmaceuticals (NASDAQ:TLX) on 9/15/2026 |
CNTB Connect Biopharma | $1.08
| 9/14/2026 | | Reiterated Rating | $7.00 | Buy | 00.00% | View details for HC Wainwright rating of Connect Biopharma (NASDAQ:CNTB) on 9/14/2026 |
ADAG Adagene | $3.20
+9.2% | 9/14/2026 | | Reiterated Rating | $7.00 | Buy | 00.00% | View details for HC Wainwright rating of Adagene (NASDAQ:ADAG) on 9/14/2026 |
CRBP Corbus Pharmaceuticals | $6.92
-3.1% | 9/14/2026 | | Reiterated Rating | $35.00 | Buy | 00.00% | View details for HC Wainwright rating of Corbus Pharmaceuticals (NASDAQ:CRBP) on 9/14/2026 |
DFTX Definium Therapeutics | $38.41
+6.2% | 9/14/2026 | | Reiterated Rating | $70.00 | Buy | 00.00% | View details for HC Wainwright rating of Definium Therapeutics (NASDAQ:DFTX) on 9/14/2026 |
GMAB Genmab A/S | $35.36
+0.1% | 9/14/2026 | | Reiterated Rating | $40.00 | Buy | 00.00% | View details for HC Wainwright rating of Genmab A/S (NASDAQ:GMAB) on 9/14/2026 |
PHAR Pharming Group | $10.52
+0.6% | 9/14/2026 | | Reiterated Rating | $37.00 | Buy | 00.00% | View details for HC Wainwright rating of Pharming Group (NASDAQ:PHAR) on 9/14/2026 |
SLDB Solid Biosciences | $7.28
-0.1% | 9/14/2026 | | Reiterated Rating | $25.00 | Buy | 00.00% | View details for HC Wainwright rating of Solid Biosciences (NASDAQ:SLDB) on 9/14/2026 |
SPRO Spero Therapeutics | $1.19
-3.3% | 9/14/2026 | | Boost Price Target | $5.00 ➝ $6.00 | Buy | 00.00% | View details for HC Wainwright rating of Spero Therapeutics (NASDAQ:SPRO) on 9/14/2026 |
CNC Centene | $62.45
+1.0% | 9/11/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Centene (NYSE:CNC) on 9/11/2026 |
DC Dakota Gold | $6.18
-6.5% | 9/11/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Dakota Gold (NYSE:DC) on 9/11/2026 |
LYEL Lyell Immunopharma | $9.74
-1.1% | 9/11/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Lyell Immunopharma (NASDAQ:LYEL) on 9/11/2026 |
MARA MARA | $12.11
-3.5% | 9/11/2026 | | Initiated Coverage | $20.00 | Buy | 00.00% | View details for HC Wainwright rating of MARA (NASDAQ:MARA) on 9/11/2026 |
OVID Ovid Therapeutics | $2.46
+2.5% | 9/11/2026 | | Boost Price Target | $4.00 ➝ $5.00 | Buy | 00.00% | View details for HC Wainwright rating of Ovid Therapeutics (NASDAQ:OVID) on 9/11/2026 |
RMTI Rockwell Medical | $8.63
+3.1% | 9/11/2026 | | Reiterated Rating | $20.00 | Buy | 00.00% | View details for HC Wainwright rating of Rockwell Medical (NASDAQ:RMTI) on 9/11/2026 |
TEM Tempus AI | $85.08
+0.1% | 9/11/2026 | | Boost Price Target | $56.00 ➝ $66.00 | Buy | 00.00% | View details for HC Wainwright rating of Tempus AI (NASDAQ:TEM) on 9/11/2026 |
VSTM Verastem | $7.77
+0.4% | 9/11/2026 | | Reiterated Rating | $18.00 | Buy | 00.00% | View details for HC Wainwright rating of Verastem (NASDAQ:VSTM) on 9/11/2026 |
IRON Disc Medicine | $64.92
-0.5% | 9/10/2026 | | Reiterated Rating | $120.00 | Buy | 00.00% | View details for HC Wainwright rating of Disc Medicine (NASDAQ:IRON) on 9/10/2026 |
ASND Ascendis Pharma A/S | $230.05
+2.0% | 9/10/2026 | | Set Price Target | $344.00 | | 00.00% | View details for HC Wainwright rating of Ascendis Pharma A/S (NASDAQ:ASND) on 9/10/2026 |
ATLX Atlas Lithium | $2.52
-6.7% | 9/10/2026 | | Lower Price Target | $12.50 ➝ $11.50 | Buy | 00.00% | View details for HC Wainwright rating of Atlas Lithium (NASDAQ:ATLX) on 9/10/2026 |
BBIO BridgeBio Pharma | $66.61
+1.6% | 9/10/2026 | | Reiterated Rating | $120.00 | Buy | 00.00% | View details for HC Wainwright rating of BridgeBio Pharma (NASDAQ:BBIO) on 9/10/2026 |
BHVN Biohaven | $13.28
+2.2% | 9/10/2026 | | Reiterated Rating | $10.00 | Neutral | 00.00% | View details for HC Wainwright rating of Biohaven (NYSE:BHVN) on 9/10/2026 |
BMRN BioMarin Pharmaceutical | $59.46
-1.3% | 9/10/2026 | | Reiterated Rating | $60.00 | Neutral | 00.00% | View details for HC Wainwright rating of BioMarin Pharmaceutical (NASDAQ:BMRN) on 9/10/2026 |
IMNM Immunome | $21.68
+1.3% | 9/10/2026 | | Reiterated Rating | $40.00 | Buy | 00.00% | View details for HC Wainwright rating of Immunome (NASDAQ:IMNM) on 9/10/2026 |
IMUX Immunic | $9.51
+1.7% | 9/10/2026 | | Reiterated Rating | $22.00 | Buy | 00.00% | View details for HC Wainwright rating of Immunic (NASDAQ:IMUX) on 9/10/2026 |
PYXS Pyxis Oncology | $2.90
+1.4% | 9/10/2026 | | Boost Price Target | $7.00 ➝ $8.00 | Buy | 00.00% | View details for HC Wainwright rating of Pyxis Oncology (NASDAQ:PYXS) on 9/10/2026 |
SPTX Seaport Therapeutics | $19.64
-8.7% | 9/10/2026 | | Reiterated Rating | $50.00 | Buy | 00.00% | View details for HC Wainwright rating of Seaport Therapeutics (NASDAQ:SPTX) on 9/10/2026 |
TYRA Tyra Biosciences | $21.45
-1.4% | 9/10/2026 | | Lower Price Target | $45.00 ➝ $30.00 | Buy | 00.00% | View details for HC Wainwright rating of Tyra Biosciences (NASDAQ:TYRA) on 9/10/2026 |
GPCR Structure Therapeutics | $35.06
-2.4% | 9/9/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of Structure Therapeutics (NASDAQ:GPCR) on 9/9/2026 |
If you keep cash in a U.S. bank account… read this NOW (Ad) Since 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every dollar while paying savers just 0.04 percent interest.
A new law, the GENIUS Act signed last summer, has cleared the way for a different kind of money to emerge this fall, one that could offer savings rates up to 6 percent.
See what Ian King, Chief Strategist at Strategic Fortunes, has uncovered about this shift before it goes live. Click here to see what Ian King found about this new savings shift |
TLSI TriSalus Life Sciences | $4.39
+1.2% | 9/9/2026 | | Initiated Coverage | $11.00 | Buy | 00.00% | View details for HC Wainwright rating of TriSalus Life Sciences (NASDAQ:TLSI) on 9/9/2026 |
EBS Emergent Biosolutions | $6.86
+1.0% | 9/9/2026 | | Reiterated Rating | $10.00 | Buy | 00.00% | View details for HC Wainwright rating of Emergent Biosolutions (NYSE:EBS) on 9/9/2026 |
EVMN Evommune | $8.38
-1.4% | 9/9/2026 | | Reiterated Rating | | Neutral | 00.00% | View details for HC Wainwright rating of Evommune (NYSE:EVMN) on 9/9/2026 |
FENC Adherex Technologies | $10.95
+3.3% | 9/9/2026 | | Reiterated Rating | $16.00 | Buy | 00.00% | View details for HC Wainwright rating of Adherex Technologies (NASDAQ:FENC) on 9/9/2026 |
IRD Opus Genetics | $5.05
+6.1% | 9/9/2026 | | Reiterated Rating | $8.00 | Buy | 00.00% | View details for HC Wainwright rating of Opus Genetics (NASDAQ:IRD) on 9/9/2026 |
NTLA Intellia Therapeutics | $11.42
-2.8% | 9/9/2026 | | Reiterated Rating | $25.00 | Buy | 00.00% | View details for HC Wainwright rating of Intellia Therapeutics (NASDAQ:NTLA) on 9/9/2026 |
PEPG PepGen | $2.59
| 9/9/2026 | | Reiterated Rating | | Buy | 00.00% | View details for HC Wainwright rating of PepGen (NASDAQ:PEPG) on 9/9/2026 |
PLX Protalix BioTherapeutics | $2.69
-1.1% | 9/9/2026 | | Reiterated Rating | $12.00 | Buy | 00.00% | View details for HC Wainwright rating of Protalix BioTherapeutics (NYSE:PLX) on 9/9/2026 |
TLSI TriSalus Life Sciences | $4.39
+1.2% | 9/9/2026 | | Initiated Coverage | $11.00 | Buy | 00.00% | View details for HC Wainwright rating of TriSalus Life Sciences (NASDAQ:TLSI) on 9/9/2026 |
USGO U.S. GoldMining | $6.92
-3.8% | 9/9/2026 | | Reiterated Rating | $30.75 | Buy | 00.00% | View details for HC Wainwright rating of U.S. GoldMining (NASDAQ:USGO) on 9/9/2026 |
